data collection: Data collection on diabetes therapy and follow-up
Study summary
CardioMET is an observational, multicenter, real-life registry, intending to collect data on patients with Type 2 Diabetes Mellitus, attending internal medicine and cardiology outpatient clinics. The aim of the registry is to characterize the cardiovascular risk profile and pharmacological management of Type 2 Diabetes Mellitus in Italy, in accordance with current ESC and AHA guidelines for primary and secondary prevention of CV disease.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Age ≥ 18 years;
* Diagnosis of type 2 diabetes mellitus (T2DM);
* Stable clinical conditions
* Outpatient settings
* Ability to understand the study procedures and provide written informed consent.
Exclusion Criteria:
* Patients with type 1 diabetes mellitus;
* Active participation in interventional studies;
* Any condition that may put the patient at risk by participating in the study.
Primary outcome measure(s)
Diabetes treatment adherence according to the most recent European Guidelines — 12-24-36-48 months Outpatients clinic treatment adherence will be measured as the percentage of patients receiving guideline-directed medical therapy prescriptions.
Trial sites (1)
Facility
City
Region
Status
Federico II University of Naples, Department of Advanced Biomedical Sciences
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
